Kelly Birch, MPH is a Senior Manager, Health Economics and Outcomes Research at Inovalon. She supports the design, execution, and project management of real-world data (RWD) analyses that aid healthcare and life sciences companies in their mission to improve patient care.
Prior to joining Inovalon, Kelly served as a Senior HEOR Writer at OPEN Health Scientific Communications, partnering with life sciences companies on strategic publication planning and scientific content development. She previously held a Senior Research Scientist role at PRECISIONheor, where she worked on the design, execution, and dissemination of diverse HEOR projects that included patient-reported outcomes assessment, qualitative research, economic evaluations, and real-world database analyses using administrative claims and electronic health record data. Her HEOR experience spans numerous therapeutic areas including oncology, psychiatry, chronic disease, infectious disease, and rare disease.
Kelly has co-authored numerous conference presentations as well as several peer-reviewed manuscripts published in journals such as Value in Health and the Journal of Managed Care and Specialty Pharmacy.
Kelly holds a Master of Public Health in Epidemiology from the University of California, Los Angeles and a Bachelor of Science in Behavioral Neuroscience from the University of San Diego.
Real-World Adherence and Persistence Among U.S. Medicare Beneficiaries Initiating Advanced Lipid Lowering Therapies
Accepted for presentation at American Society for Preventive Cardiology 2026 Congress on CVD Prevention. Findings available upon request. Contact us for more information.
A Comparative Assessment of Travel Burden and Productivity Loss for CAR T-Cell Therapy and Bispecific Antibody Treatment in Patients With Relapsed/Refractory LBCL Using U.S. Claims Data
Accepted for presentation at International Society for Pharmacoeconomics and Outcomes Research. Findings available upon request. Contact us for more information.
Outcomes of Inpatient and Outpatient Chimeric Antigen Receptor T-Cell Therapy in Newly Authorized Treatment Centers in the United States
Accepted for presentation at American Society of Hematology (ASH). Findings available upon request. Contact us for more information.

Thriving in Uncertainty: How Real-World Data Powers Life Sciences Resilience
This white paper explores how life sciences can use real-world data to anticipate uncertainty, build resilience, and drive growth.

Opioid Overdose Trends in the U.S., 2021–2024
See how opioid overdose trends have shifted since 2021, including 2024's 26.9% drop in overdose deaths, by insurance type, age, and state.